Biocomposites

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 25 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

With a singular focus on developing innovative calcium compound medical devices, Biocomposites has gained a deep expertise in musculoskeletal infections, trauma, spine and sports injuries. Connected with universities and hospitals around the world, Biocomposites continues to innovate in infection management to support surgeons and their patients.

Possessing unique characteristics for regenerating bone and managing dead space, our products are opening new possibilities for surgeons around the world in trauma, spine, sports injuries and musculoskeletal infections – one of the biggest healthcare challenges of the 21st century.

Company Growth (employees)
Type
Private
HQ
Keele, GB
Size (employees)
83 (est)+21%
Biocomposites is headquartered in Keele, GB

Biocomposites Office Locations

Biocomposites has an office in Keele
Keele, GB (HQ)
Science Park University of Keele

Biocomposites Financials and Metrics

Summary Metrics

Time since last funding

6 months

Biocomposites Financials

Biocomposites's revenue was reported to be £22.1 m in FY, 2016 which is a 41% increase from the previous period.
GBP

Revenue (FY, 2016)

22.1 m

Net income (FY, 2016)

11.7 m

EBITDA (FY, 2016)

13.4 m

EBIT (FY, 2016)

13.2 m

Cash (31-Dec-2016)

15.4 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

9 m10.3 m15.7 m22.1 m

Revenue growth, %

15%52%

Operating expense total

7.6 m7.9 m8.9 m

EBITDA

2.8 m8 m13.4 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.5 m7.3 m11.7 m

Income Taxes Paid

(728 k)(169 k)(585 k)
    GBPY, 2016

    Revenue/Employee

    293.7 k

    Financial Leverage

    1.1 x
    Show all financial metrics

    Biocomposites's Web-traffic and Trends

    Biocomposites News and Updates

    Biocomposites pulls in funding from TA Associates

    TA Associates has made an undisclosed investment in UK-based Biocomposites, a maker of calcium compound biologics. Barings provided senior loans to back the transaction. No financial terms were disclosed.

    Biocomposites Company Life and Culture

    You may also be interested in